Stocks News

LAST PRICE
25.8400
TODAY'S CHANGE (%)
Trending Down-0.8100 (-3.0394%)

Bid / Lots
24.9300/ 1
Ask / Lots
26.4300/ 1
Open / Previous Close
26.4700 / 26.6500
Day Range
Low 25.0900
High 27.1900
52 Week Range
Low 20.8400
High 49.5000
Volume
716,259
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 12, 2024
- Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference, from 4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
  4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: BEAM
  
  Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference
  
  CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer of Beam, plans to participate in a fireside chat during the 2024 Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 10:00 a.m. GMT in London.
Nov 8, 2024
- Beam Therapeutics Insider Sold Shares Worth $1,347,050, According to a Recent SEC Filing, from 4:23PM ET on Friday Nov 08, 2024 by MT Newswires
  4:23PM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: BEAM
  04:23 PM EST, 11/08/2024 (MT Newswires) -- Giuseppe Ciaramella, President, on November 06, 2024, sold 51,110 shares in Beam Therapeutics (BEAM) for $1,347,050. Following the Form 4 filing with the SEC, Ciaramella has control over a total of 109,150 ...
Nov 7, 2024
- DJ Beam Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co., from 5:01AM ET on Thursday Nov 07, 2024 by Dow Jones
  5:01AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: BEAM
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BEAM/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 07, 2024 05:01 ET (10:01 GMT)
Nov 6, 2024
- Beam Therapeutics Gets Upgrade From Leerink Partners; Shares Rise, from 2:26PM ET on Wednesday Nov 06, 2024 by MT Newswires
  2:26PM ET on Wednesday Nov 06, 2024 by MT Newswires
  Companies Mentioned: BEAM
  02:26 PM EST, 11/06/2024 (MT Newswires) -- Beam Therapeutics (BEAM) shares rose about 8% in recent trading Wednesday. Leerink Partners upgraded the company's stock to outperform from market perform and adjusted price target upwards to $39 from $27. ...
- DJ Beam Therapeutics Is Maintained at Sector Perform by RBC Capital, from 11:10AM ET on Wednesday Nov 06, 2024 by Dow Jones
  11:10AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: BEAM
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BEAM/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 06, 2024 11:10 ET (16:10 GMT)

Today
- DJ Genmab A/S Stock Falls Tuesday, Underperforms Market, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: GMAB
Yesterday
- DJ Genmab A/S Stock Falls Monday, Underperforms Market, from 12:02PM ET on Monday Nov 25, 2024 by Dow Jones
  12:02PM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: GMAB
- Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500(TM) List, from 8:03AM ET on Monday Nov 25, 2024 by Dow Jones
  8:03AM ET on Monday Nov 25, 2024 by Dow Jones
  Companies Mentioned: CPRX
Nov 22, 2024
- DJ Genmab A/S Stock Rises Friday, Outperforms Market, from 12:02PM ET on Friday Nov 22, 2024 by Dow Jones
  12:02PM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: GMAB
Nov 21, 2024
- DJ Genmab A/S Stock Rises Thursday, Outperforms Market, from 12:02PM ET on Thursday Nov 21, 2024 by Dow Jones
  12:02PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: GMAB
Nov 20, 2024
- DJ Genmab A/S Stock Falls Wednesday, Underperforms Market, from 12:02PM ET on Wednesday Nov 20, 2024 by Dow Jones
  12:02PM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: GMAB
Nov 19, 2024
- DJ Genmab A/S Stock Falls Tuesday, Underperforms Market, from 12:02PM ET on Tuesday Nov 19, 2024 by Dow Jones
  12:02PM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: GMAB
- Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences, from 8:03AM ET on Tuesday Nov 19, 2024 by Dow Jones
  8:03AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: CPRX
Nov 18, 2024
- DJ Genmab A/S Stock Rises Monday, Outperforms Market, from 12:02PM ET on Monday Nov 18, 2024 by Dow Jones
  12:02PM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: GMAB
- DJ Catalyst Pharmaceuticals Initiated at Overweight by Stephens & Co., from 10:38AM ET on Monday Nov 18, 2024 by Dow Jones
  10:38AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: CPRX

Beam Therapeutics Inc
NASDAQ:BEAMUnited States

Search Criteria

Nov 12, 2024

Beam Therapeutics to Participate in 2024 Jefferies London Healthcare Conference, from 4:01PM ET on Tuesday Nov 12, 2024 by Dow Jones

Nov 8, 2024

Beam Therapeutics Insider Sold Shares Worth $1,347,050, According to a Recent SEC Filing, from 4:23PM ET on Friday Nov 08, 2024 by MT Newswires

Nov 7, 2024

DJ Beam Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co., from 5:01AM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 6, 2024

Beam Therapeutics Gets Upgrade From Leerink Partners; Shares Rise, from 2:26PM ET on Wednesday Nov 06, 2024 by MT Newswires

DJ Beam Therapeutics Is Maintained at Sector Perform by RBC Capital, from 11:10AM ET on Wednesday Nov 06, 2024 by Dow Jones

Peers Headlines

Today

DJ Genmab A/S Stock Falls Tuesday, Underperforms Market, from 7 hours ago by Dow Jones

Yesterday

DJ Genmab A/S Stock Falls Monday, Underperforms Market, from 12:02PM ET on Monday Nov 25, 2024 by Dow Jones

Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500(TM) List, from 8:03AM ET on Monday Nov 25, 2024 by Dow Jones

Nov 22, 2024

DJ Genmab A/S Stock Rises Friday, Outperforms Market, from 12:02PM ET on Friday Nov 22, 2024 by Dow Jones

Nov 21, 2024

DJ Genmab A/S Stock Rises Thursday, Outperforms Market, from 12:02PM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 20, 2024

DJ Genmab A/S Stock Falls Wednesday, Underperforms Market, from 12:02PM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 19, 2024

DJ Genmab A/S Stock Falls Tuesday, Underperforms Market, from 12:02PM ET on Tuesday Nov 19, 2024 by Dow Jones

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences, from 8:03AM ET on Tuesday Nov 19, 2024 by Dow Jones

Nov 18, 2024

DJ Genmab A/S Stock Rises Monday, Outperforms Market, from 12:02PM ET on Monday Nov 18, 2024 by Dow Jones

DJ Catalyst Pharmaceuticals Initiated at Overweight by Stephens & Co., from 10:38AM ET on Monday Nov 18, 2024 by Dow Jones